![COVID-19 Vaccine Second-Dose Completion and Interval Between First and Second Doses Among Vaccinated Persons — United States, December 14, 2020−February 14, 2021 | MMWR COVID-19 Vaccine Second-Dose Completion and Interval Between First and Second Doses Among Vaccinated Persons — United States, December 14, 2020−February 14, 2021 | MMWR](https://www.cdc.gov/mmwr/volumes/70/wr/social-media/mm7011e2_COVID19VaccineDose2_IMAGE_12Mar21_v4_1200x627.jpg?_=39294)
COVID-19 Vaccine Second-Dose Completion and Interval Between First and Second Doses Among Vaccinated Persons — United States, December 14, 2020−February 14, 2021 | MMWR
![Pediatric Atropine Sulfate, Injection USP 0.25mg/5ml HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ATROPINE SULFATE INJECTION safely and effectively. See full prescribing information for Pediatric Atropine Sulfate, Injection USP 0.25mg/5ml HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ATROPINE SULFATE INJECTION safely and effectively. See full prescribing information for](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=Table1.jpg&id=634335)
Pediatric Atropine Sulfate, Injection USP 0.25mg/5ml HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ATROPINE SULFATE INJECTION safely and effectively. See full prescribing information for
![Comparing one dose of HPV vaccine in girls aged 9–14 years in Tanzania (DoRIS) with one dose of HPV vaccine in historical cohorts: an immunobridging analysis of a randomised controlled trial - Comparing one dose of HPV vaccine in girls aged 9–14 years in Tanzania (DoRIS) with one dose of HPV vaccine in historical cohorts: an immunobridging analysis of a randomised controlled trial -](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/06629244-ae79-4c0d-a175-e4de07408954/gr1_lrg.jpg)
Comparing one dose of HPV vaccine in girls aged 9–14 years in Tanzania (DoRIS) with one dose of HPV vaccine in historical cohorts: an immunobridging analysis of a randomised controlled trial -
Validation of Early Human Dose Prediction: A Key Metric for Compound Progression in Drug Discovery | Molecular Pharmaceutics
![COVID-19 vaccines – The difference between the third dose and a booster dose – Easy Read | Australian Government Department of Health and Aged Care COVID-19 vaccines – The difference between the third dose and a booster dose – Easy Read | Australian Government Department of Health and Aged Care](https://www.health.gov.au/sites/default/files/images/publications/2021/11/covid-19-vaccines-the-difference-between-the-third-dose-and-a-booster-dose-easy-read.png)
COVID-19 vaccines – The difference between the third dose and a booster dose – Easy Read | Australian Government Department of Health and Aged Care
![emDOCs.net – Emergency Medicine EducationPush-Dose Vasopressors: An Update for 2019 - emDOCs.net - Emergency Medicine Education emDOCs.net – Emergency Medicine EducationPush-Dose Vasopressors: An Update for 2019 - emDOCs.net - Emergency Medicine Education](http://www.emdocs.net/wp-content/uploads/2019/04/Screen-Shot-2019-04-21-at-5.23.21-PM.png)